Yellow fever vaccines and international travelers

@article{Barnett2008YellowFV,
  title={Yellow fever vaccines and international travelers},
  author={E. Barnett and A. Wilder-Smith and M. Wilson},
  journal={Expert Review of Vaccines},
  year={2008},
  volume={7},
  pages={579 - 587}
}
The growth of air travel has diminished the barriers to the spread of yellow fever, posing a threat to regions that have not previously been reached by the disease but are considered receptive, including the Middle East, coastal East Africa, the Indian subcontinent, Asia and Australia. For many decades, vaccination against yellow fever has been required for travelers entering many countries with receptive mosquito vectors in order to prevent the importation of yellow fever virus from a country… Expand
Review of the risks and benefits of yellow fever vaccination including some new analyses
  • T. Monath
  • Medicine
  • Expert review of vaccines
  • 2012
TLDR
Multiple factors should be considered in making decisions about YF vaccination, including specific destination, season of the year, local evidence for YF transmission, likelihood of exposure to vector mosquitoes and individual risk factors for YEL-AVD, with the goal of increasing vaccine coverage for travel to high-risk areas and reducing unnecessary vaccination. Expand
Mosquito-borne diseases.
  • M. Tolle
  • Geography, Medicine
  • Current problems in pediatric and adolescent health care
  • 2009
TLDR
Efforts to limit the effect of mosquito-borne diseases in endemic areas face the twin challenges of controlling mosquito populations and delivering effective public health interventions. Expand
Safety of 17D derived yellow fever vaccines
TLDR
The incidence of YFSAE has been associated with increasing age and thymus disorders, but still a number of cases with any risk factor remain unexplained, which suggests that other factors could be involved in the appearance of these postvaccinal adverse events. Expand
Evaluation of Safety Profile of Yellow Fever Vaccine in Healthy IndianTravellers: A Prospective Observational Study
TLDR
It is fair to conclude that Yellow fever vaccine is safe and well tolerated in healthy Indian travelers on a limited number of subjects. Expand
Travel patterns and health risks for patients infected with HIV.
TLDR
Endemic-born travelers infected with HIV stay abroad longer and are more likely to visit malarious regions than their Canadian-born counterparts and more research is needed to ensure the best preventive care of these special needs travelers. Expand
Undifferentiated Tropical Viral Fevers in Latin America
TLDR
The aim of this chapter is to review the most common undifferentiated tropical viral fevers in Latin America and identify the animals that act as intermediary hosts. Expand
Determinants of Compliance of Travelers with Vaccination and Malaria Prophylaxis at a Travel Clinic
TLDR
Travelers should be aware of required vaccination and malaria prophylaxis before visiting South and Central America and Asia and plans to enhance compliance of the elderly and business travelers should be contrived. Expand
Evaluating a Sick Child after Travel to Developing Countries
  • M. Tolle
  • Medicine
  • The Journal of the American Board of Family Medicine
  • 2010
TLDR
With a focus first on ruling out life-threatening disease and subsequently on an informed and efficient path to diagnosis and treatment, clinicians may confidently provide care for this challenging group of patients. Expand
Fever in the Returning Traveler
TLDR
Patients with recent travel history are diagnosed with routine infections, but serious infections such as malaria, enteric fever, and dengue fever should be on the differential diagnosis due the high morbidity and mortality in children. Expand
Trends in importation of communicable diseases into Singapore.
TLDR
It is underlines that diseases such as malaria, viral hepatitis and enteric fever occur in Singapore mainly because of importation and the proportion of imported diseases in relation to overall passenger traffic has decreased over the past 10 years. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 62 REFERENCES
Prevention of yellow fever in persons traveling to the tropics.
  • T. Monath, M. Cetron
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2002
TLDR
The likelihood of infection and illness may be high in rural areas and cannot be easily defined by existing surveillance, so physicians should vaccinate persons at risk on the basis of knowledge of the epidemiology of the disease, reports of epidemic activity, season, and the likelihood of exposure to vector mosquitoes. Expand
Yellow fever: a decade of reemergence.
TLDR
The total of 18 735 yellow fever cases and 4522 deaths reported from 1987 to 1991 represents the greatest amount of yellow fever activity reported to the World Health Organization for any 5-year period since 1948. Expand
Yellow fever immunizations: Indications and risks
TLDR
The adverse events associated with the yellow fever vaccine are described, postulated reasons for the recent recognition of these events are reviewed, and key research questions that need to be addressed in trying to understand their origin and risk factors are discussed. Expand
Urban yellow fever epidemic in western Nigeria, 1987.
TLDR
A large epidemic of urban yellow fever occurred in April and May 1987 in Oyo State, western Nigeria, and the principal vector was Aedes aegypti, breeding in domestic water containers, which probably resulted from introduction of the virus by viraemic travellers. Expand
Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
TLDR
Administration of YF vaccine is recommended for persons aged aged >or=9 months who are traveling to or living in areas of South America and Africa in which a risk exists for YFV transmission. Expand
The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice.
TLDR
The extended spectrum of diseases and events under IHR (2005) that may cause a public health emergency of international concern necessitated a revision of the existing “ International Certificate of Vaccination or Revaccination Against Yellow Fever” to the “International Certificate ofvaccination or Prophylaxis” (ICVP). Expand
First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations.
TLDR
This was the first documented outbreak of YF in Kenya, a classic example of a sylvatic transmission cycle, and surveillance in rural and urban areas outside the vaccination area should be intensified. Expand
Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events.
TLDR
It was found that the reporting rates of serious adverse events were significantly higher among vaccinees aged > or =60 years than among those 19-29 years of age, and the risk for severe illness and death due to yellow fever infection should be balanced against the risk of a serious adverse event due to YEL. Expand
Congenital Arboviral Infections: Something New, Something Old
TLDR
In 1999, West Nile virus (WNV), a member of the JEV antigenic complex of flaviviruses (family Flaviviridae) discovered in 1937, was introduced into the Western hemisphere, paralleling in some respects the emergence of JEV in northern India. Expand
Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future.
  • T. Monath
  • Biology, Medicine
  • The American journal of tropical medicine and hygiene
  • 1991
TLDR
Although discovery of the jungle cycle of yellow fever transmission in 1935 dispelled hopes of ever eradicating the disease, widescale use of vaccines in the 1940s and systematic efforts to subdue Ae. Expand
...
1
2
3
4
5
...